Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32689238 | 0.84 | EPHX2 (0.33) | EPHX2NLRP3ALDH1A1LMNAKDM4E | |
| SCHEMBL32688513 | 0.82 | MGAM (0.40) | EPHX2ALDH1A1LMNAKDM4E | |
| SCHEMBL16583778 | 0.79 | ALDH1A1 (0.32) | ALDH1A1LMNAKDM4E | |
| SCHEMBL16583816 | 0.79 | KDM4E (0.30) | ALDH1A1LMNAKDM4E | |
| SCHEMBL32689045 | 0.79 | KDM4E (0.33) | ALDH1A1LMNAKDM4E | |
| SCHEMBL4787576 | 0.75 | KDM4E (0.34) | ALDH1A1KDM4E | |
| SCHEMBL32689197 | 0.73 | KDM4E (0.34) | EPHX2ALDH1A1LMNAKDM4E | |
| SCHEMBL200325 | 0.72 | PDCD1 (0.47) | ALDH1A1KDM4E | |
| SCHEMBL455925 | 0.72 | NLRP3 (0.43) | EPHX2NLRP3ALDH1A1LMNAKDM4E | |
| SCHEMBL11791934 | 0.71 | ALDH1A1 (0.33) | EPHX2ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | EPHX2 154/4885NLRP3 2623/4885PRKCA 4375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.